New National Initiative for Precision Medicine - Genomic Medicine Sweden

Published 2017-09-14 10:19. Updated 2017-09-14 10:30Denna sida på svenska

Genomic Medicine Sweden is an initiative that, through a preparatory study, aims to build a new type of infrastructure within Swedish Healthcare that implements Precision Medicine at a national level.

GMS karta

On September 19, 2017, the initiative will have a start-up meeting at Karolinska Institutet where Swedish clinicians, diagnosticians and technicians nationwide gather together to participate in and influence the design of Genomic Medicine Sweden, GMS.

"The response has been extremely positive and we now have more than 170 registered participants from all over the country, with excellence throughout the field," says project leader Richard Rosenquist Brandell, Professor of Clinical Genetics at the Department of Molecular Medicine and Surgery. "The goal is to build a new type of infrastructure that enables World-Leading Diagnostics and Precision Medicine in Sweden."

The primary focus will be patients with rare inherited diseases and cancer, but sequencing will also be performed in other areas such as in complex diseases and the microbiome. The initiative will be organized as a broad scale collaborative project amongst different key societal stakeholders, the Swedish healthcare system, academia and SciLifeLab. 

The preparatory study was granted by Swelife/Vinnova in June. 

Start-up meeting

September 19, 2017 at Karolinska Institutet

Project leader

Professor/senior physician

Richard Rosenquist Brandell

Organizational unit: Clinical Genetics

Swelife is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s collaborative partners in healthcare, academia and industry. Swelife’s goal is to strengthen Swedish Life Science and improve public health.